[HTML] sciencedirect.com

[HTML][HTML] In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and …

Y Wang, H Li, X Xie, XH Wu, X Li, Z Zhao, S Luo… - Journal of Global …, 2020 - Elsevier
Objectives Limited therapeutic options exist for treating severe infections caused by
multidrug-resistant (MDR) and extensively drug-resistant Gram-negative bacteria (GNB). In …
被引用次数：16 相关文章

In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia …

Y Wang, H Li, X Xie, X Wu, X Li, Z Zhao… - Journal of Global …, 2019 - europepmc.org
Objectives Limited therapeutic options exist for treating severe infections caused by
multidrug-resistant (MDR) and extensively drug-resistant Gram-negative bacteria (GNB). In …

In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia …

Y Wang, H Li, X Xie, XH Wu, X Li, Z Zhao, S Luo, Z Wan… - 2020 - agris.fao.org
Objectives: Limited therapeutic options exist for treating severe infections caused by
multidrug-resistant (MDR) and extensively drug-resistant Gram-negative bacteria (GNB). In …

In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia …

Y Wang, H Li, X Xie, XH Wu, X Li… - Journal of global …, 2020 - pubmed.ncbi.nlm.nih.gov
Objectives Limited therapeutic options exist for treating severe infections caused by
multidrug-resistant (MDR) and extensively drug-resistant Gram-negative bacteria (GNB). In …